Evidence map›Paper›PMID 37089296›Full record

ReviewHeliyon2023

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.

Huisheng Ai, Nelson J Chao, David A Rizzieri, Xiaojun Huang, Thomas R Spitzer, Jianxiang Wang, Mei Guo, Armand Keating, Elizabeth F Krakow, Didier Blaise and 64 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

74 authors.

Huisheng AiChinese PLA General Hospital, China.
Nelson J ChaoDuke University, USA.
David A RizzieriNovant Health, USA.
Xiaojun HuangPeople's Hospital of Peking University, China.
Thomas R SpitzerMassachusetts General Hospital, USA.
Jianxiang WangChinese Academy of Medical Sciences Hematology Hospital, China.
Mei GuoChinese PLA General Hospital, China.
Armand KeatingUniversity of Toronto, Canada.
Elizabeth F KrakowFred Hutchinson Cancer Research Center, USA.
Didier BlaiseMarseille Cancer Research Center, France.
Jun MaHarbin Institute of Hematology and Oncology, China.
Depei WuThe First Affiliated Hospital of Soochow University, China.
John ReaganThe Warren Alpert Medical School of Brown University, USA.
Usama GergisSidney Kimmel Cancer Center, USA.
Rafael F DuarteHospital Universitario Puerta de Hierro, Spain.
Preet M ChaudharyKeck School of Medicine of University of Southern California, USA.
Kaixun HuChinese PLA General Hospital, China.
Changlin YuChinese PLA General Hospital, China.
Qiyun SunChinese PLA General Hospital, China.
Ephraim FuchsJohns Hopkins University, USA.
Bo CaiChinese PLA General Hospital, China.
Yajing HuangChinese PLA General Hospital, China.
Jianhui QiaoChinese PLA General Hospital, China.
David GottliebWestmead Hospital, Australia.
Kirk R SchultzBC Children's Hospital and Research Institute, Canada.
Mingyao LiuUniversity of Toronto, Canada.
Xiequn ChenAffiliated Hospital of Northwest University, China.
Wenming ChenBeijing Chao-yang Hospital, Capital Medical University, China.
Jianmin WangChanghai Hospital of Naval Medical University, China.
Xiaohui ZhangPeople's Hospital of Peking University, China.
Jianyong LiJiangsu Province Hospital, China.
He HuangThe First Affiliated Hospital, Zhejiang University School of Medicine, China.
Zimin SunThe First Affiliated Hospital of University of Science and Technology of China, China.
Fei LiThe First Affiliated Hospital of Nanchang University, China.
Linhua YangThe Second Hospital of Shanxi Medical University, China.
Liansheng ZhangLanzhou University Second Hospital, China.
Lijuan LiLanzhou University Second Hospital, China.
Kaiyan LiuPeople's Hospital of Peking University, China.
Jie JinThe First Affiliated Hospital, Zhejiang University School of Medicine, China.
Qifa LiuNanfang Hospital of Southern Medical University, China.
Daihong LiuChinese PLA General Hospital, China.
Chunji GaoChinese PLA General Hospital, China.
Chuanbo FanQingdao Hiser Hospital, China.
Li WeiChengdu Fifth People's Hospital, China.
Xi ZhangMedical Center of Hematology, Xinqiao Hospital, Army Medical University, Jinfeng Laboratory, China.
Liangding HuChinese PLA General Hospital, China.
Weijing ZhangBeijing Shijitan Hospital, China.
Yuyang TianHainan Cancer Hospital, China.
Weidong HanChinese PLA General Hospital, China.
Jun ZhuBeijing Cancer Hospital, China.
Zhijian XiaoChinese Academy of Medical Sciences Hematology Hospital, China.
Daobin ZhouPeking Union Medical College Hospital, China.
Bolong ZhangHarbin Institute of Hematology and Oncology, China.
Yongqian JiaWest China Hospital of Sichuan University, China.
Yongqing ZhangChinese PLA General Hospital, China.
Xiaoxiong WuChinese PLA General Hospital, China.
Xuliang ShenHeping Hospital Affiliated to Changzhi Medical College, China.
Xuzhang LuChangzhou Second People's Hospital, China.
Xinrong ZhanXinxiang Center Hospital, China.
Xiuli SunThe First Affiliated Hospital of Dalian Medical University, China.
Yi XiaoTongji Hospital, Tongji Medical College of HUST, China.
Jingbo WangAerospace Center Hospital, China.
Xiaodong ShiCapital Institute of Pediatrics, China.
Bo ZhengGeneral Hospital of Ningxia Medical University, China.
Jieping ChenSouthwest Hospital of Army Medical University, China.
Banghe DingHuai'an First People's Hospital, China.
Zhao WangBeijing Friendship Hospital, Capital Medical University, China.
Fan ZhouGeneral Hospital of Northern Theater Command, China.
Mei ZhangThe First Affiliated Hospital of Xi'an Jiaotong University, China.
Yizhuo ZhangSun Yat-sen University Cancer Center, China.
Jie SunThe First Affiliated Hospital, Zhejiang University School of Medicine, China.
Bing XiaTianjin Medical University Cancer Institute and Hospital, China.
Baoan ChenZhongda Hospital, Southeast University, China.
Liangming MaShanxi Bethune Hospital, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have shown that microtransplant (MST) could improve outcome of patients with elderly acute myeloid leukemia (EAML). To further standardize the MST therapy and improve outcomes in EAML patients, based on analysis of the literature on MST, especially MST with EAML from January 1st, 2011 to November 30th, 2022, the International Microtransplant Interest Group provides recommendations and considerations for MST in the treatment of EAML. Four major issues related to MST for treating EAML were addressed: therapeutic principle of MST (1), candidates for MST (2), induction chemotherapy regimens (3), and post-remission therapy based on MST (4). Others included donor screening, infusion of donor cells, laboratory examinations, and complications of treatment.

Indexed as

Acute myeloid leukemiaElderlyMicrotransplantRecommendations and considerations

Identifiers

PMID37089296
PMCPMC10119710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.